MAI Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
MAI Capital Management's RPRX Position: Q3 2026 in Review
MAI Capital Management reduced its Royalty Pharma (RPRX) stake by 71% in Q3 2026, selling an estimated $498K and leaving 3,494 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #1768.
MAI Capital Management first reported a position in RPRX in Q4 2024 and has held it in 8 quarters since. The position peaked at $670K in Q2 2026. 705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- MAI Capital Management held 3,494 shares of Royalty Pharma worth $204K as of Q3 2026.
- MAI Capital Management sold 8,447 Royalty Pharma shares in Q3 2026, an estimated $498K.
- Royalty Pharma made up ﹤0.01% of MAI Capital Management's portfolio in Q3 2026, its #1768 holding.
- MAI Capital Management first reported a position in Royalty Pharma in Q4 2024 and has held it in 8 quarters since.
- MAI Capital Management's Royalty Pharma position peaked at $670K in Q2 2026.
- 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on MAI Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.